Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

APHID- Sensitivity and Specificity of a Medication Reconciliation Technology - A Primary Care Randomized Controlled Trial

NCT02135731 is registered in ClinicalTrials.gov with Blake Lesselroth as lead sponsor.

NCT NCT02135731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02135731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
APHID- Sensitivity and Specificity of a Medication Reconciliation Technology - A Primary Care Randomized Controlled Trial
Lead sponsor
Blake Lesselroth
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2009
Completion date
January 31, 2012
Enrollment
220 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

medication review